VEGFC antibody
Quick Overview for VEGFC antibody (ABIN1589950)
Target
See all VEGFC AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- VEGF-C antibody
-
Specificity
- Recombinant human VEGF-C
-
Cross-Reactivity
- Rat
-
Cross-Reactivity (Details)
- This antibody detects human and rat VEGF-C in Western blots. No cross-reactivity is shown with VEGF-A.
-
Characteristics
-
Chromosomal location: 11q13
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with recombinant human VEGF-C recombinant protein). -
Purification
- The IgG fraction of culture supernatant was purified by Protein G affinity chromatography.
-
Immunogen
- Recombinant human VEGF-C
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Western blot: Use at 1-5 μg/mL, ELISA: Use at 2-10 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Centrifuge vial prior to opening.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
-
Expiry Date
- 24 months
-
-
- VEGFC (Vascular Endothelial Growth Factor C (VEGFC))
-
Alternative Name
- VEGF-C
-
Background
- Vascular endothelial growth factor C, VEGFC, VRP, Flt4-L,VEGF-C, also known as Vascular Endothelial Growth Factor Related Protein (VRP), is a recently discovered VEGF growth factor family member that is most closely related to VEGF-D. The human VEGF-C cDNA encodes a pre-pro-protein of 416 amino acids residues. It is almost identical to the mouse VEGF-C protein. Similar to VEGF-D, VEGF-C has a VEGF homology domain spanning the middle third of the precursor molecule and long N- and C-terminal extensions. In adults, VEGF-C is highly expressed in heart, placenta, ovary and small intestine. Recombinant human VEGF-C, lacking the N- and C-terminal extensions and containing only the middle VEGF homology domain, forms primarily non-covalently linked dimers. This protein is a ligand for both VEGFR-2/KDR and VEGFR-3/FLT-4. Since VEGFR-3 is strongly expressed in lymphatic endothelial cells, it has been postulated that VEGF-C is involved in the regulation of the growth and/or differentiation of lymphatic endothelium. Although recombinant human VEGF-C is also a mitogen for vascular endothelial cells, it is much less potent than VEGF-A. The recombinant human VEGF-C contains 115 amino acids residues and was fused to a His-tag (6x His) at the C-terminal end. As a result of glycosylation VEGF-C migrates as an 18-24 kDa protein in SDS-PAGE under reducing conditions.
-
Gene ID
- 7424
-
NCBI Accession
- NM_005429, NP_005420
-
UniProt
- P49767
-
Pathways
- RTK Signaling, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-